Close Menu

MilliporeSigma

Millipore said that the technology will be used to develop a range of new multiplex immunoassay kits that can be used with the Luminex xMAP platform.

At ABRF’s annual conference this week, its various research groups presented preliminary results from their studies. One study found that clinical labs had trouble detecting PSA using standard ELISAs, which to some degree was a validation of proteomics.

Industry Briefs: Feb 12, 2009

Premium

Life Technologies, Agilent, Protein Discovery, Sigma-Aldrich, Intus, HealthLinx, Origene

Millipore is betting that the buy, which is expected to close in the next several weeks, will provide its customers a powerful cell biology/protein expression-analysis tool for the benchtop.

The firm's Bioscience division had a strong year, posting 10 percent revenue growth.

Gentel believes its APiX assays and platform will be attractive to both its core pharma customers, who are interested in adding new assays to compound screening programs, and to new academic customers, who might be attracted to the system's lower cost.

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.